Spyre Therapeutics, Inc 10-K for FY2024
Spyre Therapeutics, Inc. (SYRE)
10-K
2025-02-27
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Spyre Therapeutics, Inc filed this 10-K on February 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $886K a year earlier
- Net loss
- $208.02M
- compared with a net loss of $338.79M a year earlier